LBBW Aktienanleihe NDA 24.01.2025/ DE000LB4UUE3 /
22/05/2024 09:14:02 | Var.-0.45 | Denaro12:50:29 | Lettera12:50:29 | Sottostante | Prezzo di esercizio | Expiration date | Tipo di opzione |
---|---|---|---|---|---|---|---|
99.62EUR | -0.45% | 99.34 Quantità in denaro: 250,000 |
99.54 Quantità in lettera: 250,000 |
AURUBIS AG | 60.00 EUR | 24/01/2025 | Call |
Newsfile Corp
13:00
Flow Beverage Corp. to Present at Water Tower Research's Inaugural Consumer Products Virtual Investo...
GlobeNewswire
13:00
Entero Therapeutics to Present Corporate Update at 2024 BIO International Convention
GlobeNewswire
13:00
Medicenna to Present Clinical Update on the MDNA11 ABILITY-1 Trial at the Upcoming Sachs 10th Annual...
GlobeNewswire
13:00
Achilles Therapeutics Announces Research Collaboration with Arcturus Therapeutics to Explore Second-...
GlobeNewswire
13:00
Cartesian Therapeutics Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for De...
GlobeNewswire
13:00
Will AI Make Leaders Obsolete? AIIR Teams Up with Microsoft and Wharton to Consider the Implications
GlobeNewswire
13:00
Atea Pharmaceuticals Presents New Data Showcasing Potential Best-in-Class Combination Profile of Bem...
GlobeNewswire
13:00
Nokia successfully completes acquisition of Fenix Group, accelerating U.S. strategy
GlobeNewswire
12:56
Gate.io Celebrates 11th Anniversary with Prize Activities and Vision for the Future
GlobeNewswire
12:55
Antion Biosciences announces development of safety-enhanced and off-the-shelf CAR T-cells for autoim...
Newsfile Corp
12:36
Early Leak Unveils Exciting Lineup of Speakers and Sponsors for ADFO Summit 2024